Literature DB >> 19541710

Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma.

C J Bossley1, S Saglani, C Kavanagh, D N R Payne, N Wilson, L Tsartsali, M Rosenthal, I M Balfour-Lynn, A G Nicholson, A Bush.   

Abstract

This study describes the clinical characteristics and corticosteroid responsiveness of children with difficult asthma (DA). We hypothesised that complete corticosteroid responsiveness (defined as improved symptoms, normal spirometry, normal exhaled nitric oxide fraction (F(eNO)) and no bronchodilator responsiveness (BDR <12%)) is uncommon in paediatric DA. We report on 102 children, mean+/-sd age 11.6+/-2.8 yrs, with DA in a cross-sectional study. 89 children underwent spirometry, BDR and F(eNO) before and after 2 weeks of systemic corticosteroids (corticosteroid response study). Bronchoscopy was performed after the corticosteroid trial. Of the 102 patients in the cross-sectional study, 88 (86%) were atopic, 60 (59%) were male and 52 (51%) had additional or alternative diagnoses. Out of the 81 patients in the corticosteroid response study, nine (11%) were complete responders. Of the 75 patients with symptom data available, 37 (49%) responded symptomatically, which was less likely if there were smokers in the home (OR 0.31, 95% CI 0.02-0.82). Of the 75 patients with available spirometry data, 35 (46%) had normal spirometry, with associations being BAL eosinophilia (OR 5.43, 95% CI 1.13-26.07) and high baseline forced expiratory volume in 1 s (FEV(1)) (OR 1.08, 95% CI 1.02-1.12). Of these 75 patients, BDR data were available in 64, of whom 36 (56%) had <12% BDR. F(eNO) data was available in 70 patients, of whom 53 (75%) had normal F(eNO). Airflow limitation data was available in 75 patients, of whom 17 (26%) had persistent airflow limitation, which was associated with low baseline FEV(1) (OR 0.93, 95% CI 0.90-0.97). Only 11% of DA children exhibited complete corticosteroid responsiveness. The rarity of complete corticosteroid responsiveness suggests alternative therapies are needed for children with DA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19541710      PMCID: PMC3471127          DOI: 10.1183/09031936.00186508

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  34 in total

1.  Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma.

Authors:  Emmanouil Paraskakis; Caterina Brindicci; Louise Fleming; Renata Krol; Sergei A Kharitonov; Nicola M Wilson; Peter J Barnes; Andrew Bush
Journal:  Am J Respir Crit Care Med       Date:  2006-04-20       Impact factor: 21.405

2.  Intramuscular triamcinolone for difficult asthma.

Authors:  Jayachandran R Panickar; Priti Kenia; Michael Silverman; Jonathan Grigg
Journal:  Pediatr Pulmonol       Date:  2005-05

3.  Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program.

Authors:  Wendy C Moore; Eugene R Bleecker; Douglas Curran-Everett; Serpil C Erzurum; Bill T Ameredes; Leonard Bacharier; William J Calhoun; Mario Castro; Kian Fan Chung; Melissa P Clark; Raed A Dweik; Anne M Fitzpatrick; Benjamin Gaston; Mark Hew; Iftikhar Hussain; Nizar N Jarjour; Elliot Israel; Bruce D Levy; James R Murphy; Stephen P Peters; W Gerald Teague; Deborah A Meyers; William W Busse; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2007-02       Impact factor: 10.793

Review 4.  Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.

Authors:  S Kharitonov; K Alving; P J Barnes
Journal:  Eur Respir J       Date:  1997-07       Impact factor: 16.671

5.  Standardization of Spirometry, 1994 Update. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

6.  Is a two-week trial of oral prednisolone predictive of target lung function in pediatric asthma?

Authors:  Christiane Lex; Donald N R Payne; Angela Zacharasiewicz; Albert M Li; Andrew G Nicholson; Nicola M Wilson; Andrew Bush
Journal:  Pediatr Pulmonol       Date:  2005-06

7.  Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency.

Authors:  E Hägg; K Asplund; F Lithner
Journal:  Clin Endocrinol (Oxf)       Date:  1987-02       Impact factor: 3.478

8.  Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years.

Authors:  Frederik Buchvald; Eugenio Baraldi; Silvia Carraro; Benjamin Gaston; Johan De Jongste; Mariëlle W H Pijnenburg; Philip E Silkoff; Hans Bisgaard
Journal:  J Allergy Clin Immunol       Date:  2005-06       Impact factor: 10.793

9.  Exhaled nitric oxide after a single dose of intramuscular triamcinolone in children with difficult to control asthma.

Authors:  Jayachandran R Panickar; Neha Bhatnagar; Jonathan Grigg
Journal:  Pediatr Pulmonol       Date:  2007-07

10.  Can HRCT be used as a marker of airway remodelling in children with difficult asthma?

Authors:  S Saglani; G Papaioannou; L Khoo; M Ujita; P K Jeffery; C Owens; D M Hansell; D N Payne; A Bush
Journal:  Respir Res       Date:  2006-03-27
View more
  36 in total

Review 1.  Management of severe asthma in children.

Authors:  Andrew Bush; Sejal Saglani
Journal:  Lancet       Date:  2010-09-04       Impact factor: 79.321

2.  Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health/National Heart, Lung, and Blood Institute Severe Asthma Research Program.

Authors:  Anne M Fitzpatrick; W Gerald Teague; Deborah A Meyers; Stephen P Peters; Xingnan Li; Huashi Li; Sally E Wenzel; Shean Aujla; Mario Castro; Leonard B Bacharier; Benjamin M Gaston; Eugene R Bleecker; Wendy C Moore
Journal:  J Allergy Clin Immunol       Date:  2010-12-31       Impact factor: 10.793

3.  Translating Asthma: Dissecting the Role of Metabolomics, Genomics and Personalized Medicine.

Authors:  Andrew Bush
Journal:  Indian J Pediatr       Date:  2017-11-29       Impact factor: 1.967

Review 4.  Severe asthma in school-age children: evaluation and phenotypic advances.

Authors:  Andrea Coverstone; Leonard B Bacharier; Anne M Fitzpatrick
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

5.  Smokers who have children with asthma: Perceptions about child secondhand smoke exposure and tobacco use initiation and parental willingness to participate in child-focused tobacco interventions.

Authors:  Ashley H Clawson; Elizabeth L McQuaid; Belinda Borrelli
Journal:  J Asthma       Date:  2017-09-06       Impact factor: 2.515

Review 6.  Severe asthma in childhood: recent advances in phenotyping and pathogenesis.

Authors:  Anne M Fitzpatrick; Carlos E Baena-Cagnani; Leonard B Bacharier
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-04

7.  Cysteine oxidation impairs systemic glucocorticoid responsiveness in children with difficult-to-treat asthma.

Authors:  Susan T Stephenson; Lou Ann S Brown; My N Helms; Hongyan Qu; Sheena D Brown; Milton R Brown; Anne M Fitzpatrick
Journal:  J Allergy Clin Immunol       Date:  2015-03-06       Impact factor: 10.793

8.  Systemic Corticosteroid Responses in Children with Severe Asthma: Phenotypic and Endotypic Features.

Authors:  Anne M Fitzpatrick; Susan T Stephenson; Milton R Brown; Khristopher Nguyen; Shaneka Douglas; Lou Ann S Brown
Journal:  J Allergy Clin Immunol Pract       Date:  2016-09-21

9.  Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma.

Authors:  Wanda Phipatanakul; David T Mauger; Ronald L Sorkness; Jonathan M Gaffin; Fernando Holguin; Prescott G Woodruff; Ngoc P Ly; Leonard B Bacharier; Nirav R Bhakta; Wendy C Moore; Eugene R Bleecker; Annette T Hastie; Deborah A Meyers; Mario Castro; John V Fahy; Anne M Fitzpatrick; Benjamin M Gaston; Nizar N Jarjour; Bruce D Levy; Stephen P Peters; W Gerald Teague; Merritt Fajt; Sally E Wenzel; Serpil C Erzurum; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2017-06-01       Impact factor: 21.405

10.  Children with severe asthma have unique oxidative stress-associated metabolomic profiles.

Authors:  Anne M Fitzpatrick; Youngja Park; Lou Ann S Brown; Dean P Jones
Journal:  J Allergy Clin Immunol       Date:  2014-01       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.